Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-09

Clinical Trial Update: Dilated Versus Non-Dilated Wavefront Corrections for Patients With Down Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating dilated versus non-dilated wavefront corrections for correcting refractive errors in patients with Down syndrome has completed, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ohio State University | Conditions: Down Syndrome, Refractive Errors | Phase 2 | Status: COMPLETED | Results posted: 2026-03-09